Concepedia
Statistics
Publications
31
Citations
1.3K
H-Index
20
Active since
2001
Affiliations
Dow Chemical (United States)(Current)
Georgetown University
Georgetown University Medical Center
Dow Chemical (India)
Thomas Jefferson University
Matthew J. LeBaron is an author at Dow Chemical (United States) specializing in life sciences, toxicology, and molecular biology.
Publications per year
2001–2020
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells
Ahmed Sultan, Jianwu Xie, Matthew J. LeBaron et al. · Oncogene · 2004 · 197 citations
Life Sciences, Cell Biology, Molecular Biology +16
Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade
Hongzhen Li, Tommi J. Ahonen, Kalle Alanen et al. · Cancer Research · 2004 · 177 citations · Full text
Medicine, Molecular Biology, Oncology +15
Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells
Tommi J. Ahonen, Jianwu Xie, Matthew J. LeBaron et al. · Journal of Biological Chemistry · 2003 · 136 citations · Full text
Life Sciences, Molecular Biology, Oncology +11
Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression
Hiroko Yamashita, Marja T. Nevalainen, Jun Xu et al. · Molecular and Cellular Endocrinology · 2001 · 79 citations
Life Sciences, Biochemistry, Molecular Biology +10
Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice
Fransiscus E. Utama, Matthew J. LeBaron, Lynn M. Neilson et al. · Journal of Endocrinology · 2006 · 64 citations · Full text
Life Sciences, Endocrinology, Oncology +14
1–5 of 31